FDA NDC Directory · JSON-LD · Markdown

Atovaquone

NDC 0121-1016 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Labeler / ManufacturerPAI Holdings, LLC dba PAI Pharma
Marketing categoryAbbreviated NDA (generic) · App ANDA214272
Dosage form / routeSUSPENSION · ORAL
Active ingredientsATOVAQUONE (750 mg/5mL)
Marketing started20240110
Package count2

External sources

Source: openFDA. Public-domain (CC0).